Novel Therapies for Generalized Myasthenia Gravis: Insights Into FcRn and Complement Inhibition

20260 citationsJournal Article

Authors

Verena Samara · University of Nevada, Reno

Neeharika Thottempudi · Carson Tahoe Regional Medical Center

Olivia Franke · Carson Tahoe Regional Medical Center

Burton J. Tabaac · University of Nevada, Reno

Abstract

These therapies offer personalized, effective options for MG management, though challenges in cost and access remain. Future research should address long-term outcomes and biomarkers.

Topics & Keywords

Myasthenia Gravis and Thymoma Peripheral Neuropathies and Disorders Coagulation, Bradykinin, Polyphosphates, and Angioedema

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: American Journal of Therapeutics

Volume 33, Issue 1, pp. e46-e49

DOI: 10.1097/mjt.0000000000002052

Field-Weighted Citation Impact: 0.00